Followers | 6 |
Posts | 2155 |
Boards Moderated | 0 |
Alias Born | 11/26/2014 |
Friday, March 01, 2019 12:18:55 PM
About 1 year ago Odidi called me after I sent him an email saying I thought that his new China business was an opportunistic venture on his part to unjustly personally capitalize on IPCI generic approvals. He felt the need to defend himself and he told me the following:
1. Smart Pharma was set up to make drugs for African ailments. I told him he I thought he was breaching his agreement with IPCI and competing with them. He said he can start as many companies as he wants as long as they do not compete with IPCI. He also said Smart Pharma was not competing with IPCI.
2. He also said IPCI went to China to investigate 1. sourcing cheaper raw materials 2. investigate if generics could be manufactured by another party at lower cost. He said Smart Pharma would play no role in these items.
In my opinion, what I got from the whole thing was he went to China on IPCI's dime and set up a competing company. He got caught doing so, so he made a minimal statement about IPCI business in China to justify his personal endeavor that was likely paid for by IPCI shareholders.
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
- L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - IPCI • PR Newswire (Canada) • 06/08/2023 05:30:00 PM
- Canadian Investment Regulatory Organization Trade Resumption - IPCI • PR Newswire (Canada) • 06/08/2023 05:28:00 PM
- Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results • PR Newswire (Canada) • 06/06/2023 10:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM